Eneida R. Nemecek, M.D., M.S., M.B.A.
- Professor of Medicine, School of Medicine
- Professor of Pediatrics, School of Medicine
- Director, Pediatric Bone Marrow Transplant Program, Doernbecher Children’s Hospital
- Associate Director of Clinical Research, OHSU Knight Cancer Institute, School of Medicine
- Nancy Jaggar Blount Endowed Professor of Pediatric Oncology
Biography
I focus my work on gaining a better understanding of pediatric cancers and other diseases that can be treated with bone marrow transplantation. As the medical director for clinical research at the OHSU Knight Cancer Institute, I collaborate with researchers at OHSU and around the world to advance knowledge in pediatric cancer and bone marrow transplants.
I also work with national and international organizations, including the Children's Oncology Group, the Pediatric Blood and Marrow Transplant Consortium, the Bone Marrow Transplant Clinical Trials Network, and the Center for International Blood and Marrow Transplant Research.
Through these partnerships, patients receiving bone marrow transplants at OHSU Doernbecher Children's Hospital have access to a variety of clinical trials that test innovative treatments.
Education and training
-
Degrees
- B.S., 1992, University of Puerto Rico
- M.D., 1996, University of Puerto Rico School of Medicine
- M.S., 2004, University of Washington
- M.B.A., 2013, Oregon Health & Science University
-
Residency
- Pediatrics, Rainbow Babies and Children’s Hospital, Case Western Reserve University, 1999
-
Fellowship
- Pediatric hematology/oncology, Fred Hutchinson Cancer Research Center, University of Washington, 2002
-
Certifications
- National Board of Medical Examiners, 1997
- American Board of Pediatric Subspecialties, Pediatrics (2000)
- Pediatric Hematology/Oncology (2004)
Memberships and associations:
- American Society of Pediatric Hematology/Oncology
- American Society of Hematology
- American Society of Transplantation & Cellular Therapy
- International Society of Cell & Gene Therapy
Areas of interest
- Graft vs. host disease
- Diversity and Healthcare Disparities
- Cellular therapies